{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:27:40Z","timestamp":1791908860221,"version":"4.3.4"},"reference-count":125,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"EMD Millipore Corporation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Advances"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.biotechadv.2015.11.005","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T12:18:56Z","timestamp":1449058736000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Clarification of vaccines: An overview of filter based technology trends and best practices"],"prefix":"10.1016","volume":"34","author":[{"given":"Lise","family":"Besnard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fettig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Gousseinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Laroudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Scanlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyabrata","family":"Pattnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biotechadv.2015.11.005_bb0005","unstructured":"Andre, B.R., Champluvier, B.P.Z., 2010. Method for producing virus from cell culture involving homogenization. Worldwide patent application WO2010128100 A1."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/bp980106m","article-title":"Large-scale processing of recombinant retroviruses for gene therapy","volume":"15","author":"Andreadis","year":"1999","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0015","unstructured":"Antoniou, C., 2010. Plasmid DNA clarification. United State patent application 20050112753 A1."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0020","series-title":"Workshop on the Application of Virus-like Particle Technology to Malaria Vaccine Development. September 22\u201323, 2009","article-title":"Qb based vaccines","author":"Bachman","year":"2009"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0025","first-page":"18","article-title":"21st century vaccine manufacturing","volume":"4","author":"Ball","year":"2009","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00350404","article-title":"Downstream processing of insect cell cultures","volume":"20","author":"Bernard","year":"1996","journal-title":"Cytotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0035","series-title":"Workshop on the Application of Virus-like Particle Technology to Malaria Vaccine Development. September 22\u201323, 2009","article-title":"Case study: recombinant virus-like particle vaccines: Recombivax-HB\u00ae and Gardasil\u00ae","author":"Bryan","year":"2009"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0040","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/hum.2010.250","article-title":"Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02-to 200-liter cultures","volume":"22","author":"Cecchini","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0045","author":"Cervarix"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0050","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/bp000155a","article-title":"Separation of pure and immunoreactive virus-like particles using gel filtration chromatography following immobilized metal ion affinity chromatography","volume":"17","author":"Cheng","year":"2001","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/prep.1999.1155","article-title":"Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae","volume":"17","author":"Cook","year":"1999","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0060","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.vaccine.2012.01.016","article-title":"Recombinant protein vaccines produced in insect cells","volume":"30","author":"Cox","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bp000017l","article-title":"Modeling retrovirus production for gene therapy. 2. Integrated optimization of bioreaction and downstream processing","volume":"16","author":"Cruz","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MB:21:1:057","article-title":"Validation of biopharmaceutical purification processes for virus clearance evaluation","volume":"21","author":"Darling","year":"2002","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0075","unstructured":"De Vocht, M.L., Veenstra, M., 2013. Process for adenovirus purification from high cell density cultures. United States patent application US8470585 B2."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0080","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1016\/j.vaccine.2007.01.102","article-title":"Rotavirus vaccines \u2014 an update","volume":"25","author":"Dennehy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100879","article-title":"Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01","volume":"9","author":"Dietrich","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0090","series-title":"The Development of a Process and Quality Control Method for a Conjugate Vaccine Against Streptococcus pneumoniae Serotype 1","author":"Edmonds-Smith","year":"2013"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0095","unstructured":"Eichhorn, U., 2008. Influenza vaccine composition. United States patent application US7316813 B2."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0100","article-title":"When downstream process is able to withstand upstream changes! An example of clarification sequence optimization in viral vaccine production","volume":"2011","author":"Fabre","year":"2011","journal-title":"BioP Intl"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0105","author":"FDA"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/gt.2012.52","article-title":"Bioprocess development for canine adenovirus type 2 vectors","volume":"4","author":"Fernandes","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/erv.12.153","article-title":"Insect cells as a production platform of complex virus-like particles","volume":"12","author":"Fernandes","year":"2013","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jbiotec.2015.03.030","article-title":"Enveloped virus flocculation and removal in osmolyte solutions","volume":"206","author":"Gencoglu","year":"2015","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jbiotec.2014.06.011","article-title":"Porcine parvovirus flocculation and removal in the presence of osmolytes","volume":"186","author":"Gencoglu","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0130","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/S0264-410X(00)00502-8","article-title":"Recombinant attenuated bacteria for the delivery of subunit vaccines","volume":"19","author":"Gentschev","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0135","series-title":"Vaccine Technology IV","article-title":"High cell density cultivations for influenza virus production using suspension cells","volume":"Vol. 17","author":"Genzel","year":"2013"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-62703-733-4_23","article-title":"Vaccine production: upstream processing with adherent or suspension cell lines","volume":"1104","author":"Genzel","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0145","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","article-title":"High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells","volume":"32","author":"Genzel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2012.11.006","article-title":"Current trends in separation of plasmid DNA vaccines: a review","volume":"760","author":"Ghanem","year":"2013","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/bit.20406","article-title":"Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA","volume":"91","author":"Goerke","year":"2005","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/BA20020075","article-title":"Purification of capsular polysaccharide from Streptococcus pneumoniae serotype 23F by a procedure suitable for scale-up","volume":"37","author":"Gon\u00e7alves","year":"2003","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0165","series-title":"Communicating Current Research and Educational Topics and Trends in Applied Microbiology","first-page":"450","article-title":"Simple and efficient method of bacterial polysaccharides purification for vaccines production using hydrolytic enzymes and tangential flow ultrafiltration","volume":"Vol. I","author":"Gon\u00e7alves","year":"2007"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0170","first-page":"59","article-title":"Nucleic acid impurity reduction in viral vaccine manufacturing","volume":"12","author":"Gousseinov","year":"2014","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1128\/AEM.39.3.500-504.1980","article-title":"Simple method for the concentration of influenza virus from allantoic fluid on microporous filters","volume":"39","author":"Goyal","year":"1980","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0180","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.17.2.465-493.2004","article-title":"Foot-and-mouth disease","volume":"17","author":"Grubman","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0185","series-title":"Biopharmaceutical Process Development and Manufacturing","author":"Guide","year":"2013"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0190","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1016\/j.vaccine.2011.04.124","article-title":"An international technology platform for influenza vaccines","volume":"29","author":"Hendriks","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0195","unstructured":"Hermens, W.T.J., Smith, J.P., 2013. Removal of contaminating viruses from aav preparations. Patent Application WO2013036118 A1."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0200","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/BJ20040007","article-title":"Enhancement of correct protein folding in vivo by a non-lytic baculovirus","volume":"382","author":"Ho","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0205","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1016\/j.vaccine.2007.03.017","article-title":"Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris","volume":"25","author":"Hughes","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0210","first-page":"38","article-title":"Impact of cell density and viability on primary clarification of mammalian cell broth \u2014 an analysis using disc-stack centrifugation and charged depth filtration","volume":"5","author":"Iammarino","year":"2007","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-003-1223-9","article-title":"Insect cell culture for industrial production of recombinant proteins","volume":"62","author":"Ikonomou","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0220","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/bit.24493","article-title":"Vaccine process technology","volume":"109","author":"Josefsberg","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/bit.21139","article-title":"Harvesting and concentration of human in influenza A virus produced in serum-free mammalian cell culture for the production of vaccines","volume":"97","author":"Kalbfuss","year":"2007","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/BA20070174","article-title":"Large-scale plasmid DNA processing: evidence that cell harvesting and storage methods affect yield of supercoiled plasmid DNA","volume":"51","author":"Kong","year":"2008","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.provac.2010.03.014","article-title":"Development of an efficient and scalable method for processing and purification of Vi capsular polysaccharide","volume":"2","author":"Kothari","year":"2010","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0240","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1016\/j.vaccine.2013.08.037","article-title":"A novel method for purification of Vi capsular polysaccharide produced by Salmonella enterica subspecies enterica serovar typhi","volume":"31","author":"Kothari","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0245","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molmed.2010.05.002","article-title":"Alternative influenza vaccines made by insect cells","volume":"16","author":"Krammer","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0250","first-page":"s14","article-title":"Tangential flow filtration for recovery of acellular pertussis vaccine components","volume":"21","author":"Kumar","year":"2009","journal-title":"Biopharm Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0255","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0260","series-title":"Biochemistry Technology Division Abstracts. American Chemical Society Conference, New Orleans. BIOT 151 [625657]","article-title":"Enzymatic versus chemical pretreatment of the fermentation broth of N. meningitidis to improve harvest recovery","author":"Lages","year":"2003"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0265","unstructured":"Lampson, G.P., Machlowitz, R.A., 1970. Process for producing purified concentrated influenza virus. United States patent application US3547779 A."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0270","first-page":"32","article-title":"Efficient, scalable clarification of diverse bioprocess streams using a novel pilot-scale tubular bowl centrifuge","volume":"3","author":"Lander","year":"2005","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0275","article-title":"Production and purification of measles virus for oncolytic virotherapy clinical trials","volume":"9","author":"Langfield","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0280","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/bit.20587","article-title":"Robust scale-up of dead end filtration: impact of filter fouling mechanism and flow distribution","volume":"92","author":"Laska","year":"2005","journal-title":"Biotechnol. Bioeng."},{"issue":"8","key":"10.1016\/j.biotechadv.2015.11.005_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000537","article-title":"Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus\u2013host interaction","volume":"5","author":"Li","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0290","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","article-title":"The development of a recombinant hepatitis E vaccine HEV 239","volume":"11","author":"Li","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0295","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0300","doi-asserted-by":"crossref","first-page":"117","DOI":"10.20506\/rst.26.1.1733","article-title":"Antigen and vaccine banks: technical requirements and the role of the European antigen bank in emergency foot and mouth disease vaccination","volume":"26","author":"Lombard","year":"2007","journal-title":"Rev. sci. tech. Off. int. Epiz."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0305","first-page":"385","article-title":"Purification of Streptococcus pneumonie capsular polysaccharides using aluminium phosphate and ethanol","volume":"6","author":"Macha","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2012.06.008","article-title":"Mechanical properties of viruses analyzed by atomic force microscopy: a virological perspective","volume":"168","author":"Mateu","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb9000","article-title":"Bacterial Vaccines","volume":"D001428","author":"MeSH","year":"2002","journal-title":"National Library of Medicine - medical subject headings."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0315","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2672.2010.04663.x","article-title":"Isoelectric points of viruses","volume":"109","author":"Michen","year":"2010","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0320","doi-asserted-by":"crossref","first-page":"504831","DOI":"10.1155\/2015\/504831","article-title":"Current and emerging cell culture manufacturing technologies for influenza vaccines","volume":"2015","author":"Mili\u00e1n","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0325","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1038\/sj.gt.3302624","article-title":"Downstream processing of viral vectors and vaccines","volume":"12","author":"Morenweiser","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0330","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5897\/IJBMBR12.014","article-title":"Large scale recovery of tetanus toxin and toxoid from fermentation broth by microporous tangential flow filtration","volume":"4","author":"Muniandi","year":"2013","journal-title":"Intl. J. Biotech. Mol. Biol. Res."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.12665\/J53.Namatovu","article-title":"Evaluation of filtration products in the production of adenovirus candidates used in vaccine production: overview and case study","volume":"5","author":"Namatovu","year":"2006","journal-title":"Bioprocessing"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0340","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jviromet.2013.10.017","article-title":"Use of hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells","volume":"195","author":"Negrete","year":"2014","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0345","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bit.25545","article-title":"Improved virus purification processes for vaccines and gene therapy","volume":"112","author":"Nestola","year":"2015","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0350","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-60761-913-0_16","article-title":"Purification of proteins from baculovirus-infected insect cells","volume":"681","author":"O'Shaughnessy","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0355","series-title":"Fields Virology","first-page":"1648","article-title":"Orthomyxoviridae: the viruses and their replication","author":"Palese","year":"2007"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0360","article-title":"Plasmid DNA production and purification [webinar]","author":"Palmieri","year":"2010"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0365","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.vaccine.2014.02.036","article-title":"Development of a membrane adsorber based capture step for the purification of yellow fever virus","volume":"32","author":"Pato","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0370","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12665\/J123.Pattnaik","article-title":"Expediting clinical batch production of viral-vectored vaccines and gene therapy products","volume":"12","author":"Pattnaik","year":"2013","journal-title":"Bioprocess. J."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0375","first-page":"54","article-title":"Use of membrane technology in the bioprocessing of therapeutic proteins from inclusion bodies of E. coli","volume":"7","author":"Pattnaik","year":"2009","journal-title":"Bioprocess Int."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/bit.20098","article-title":"Extracellular enzyme loss during polyelectrolyte flocculation of cells from fermentation broth","volume":"87","author":"Pearson","year":"2004","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0385","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jbiotec.2006.08.002","article-title":"Downstream processing of triple layered rotavirus like particles","volume":"127","author":"Peixoto","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0390","series-title":"9th Vaccine & ISV Annual Global Congress 2015, 18\u201320 October 2015, Seoul","article-title":"Production and purification of virus like particle (VLP) based Hepatitis C vaccine candidate","author":"Peixoto","year":"2015"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0395","series-title":"Vaccines","author":"Plotkin","year":"2013"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0400","unstructured":"Prasad, A.K., 2011. Multivalent pneumococcal polysaccharide\u2013protein conjugate composition. Patent US 7955605 B2"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0405","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cep.2003.02.002","article-title":"Design of flowsheets for the recovery and purification of plasmids for gene therapy and DNA vaccination","volume":"43","author":"Prazeres","year":"2004","journal-title":"Chem. Eng. Process."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0410","doi-asserted-by":"crossref","first-page":"30","DOI":"10.12665\/J111.Raghunath","article-title":"Best practices for optimization and scale up of TFF microfiltration processes","volume":"11","author":"Raghunath","year":"2012","journal-title":"Bioprocessing"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0415","first-page":"102","article-title":"Evaluation of microporous tangential-flow filtration in the production of diphtheria and pertussis vaccine","volume":"16","author":"Rao","year":"1992","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0420","series-title":"Vaccine Analysis: Strategies, Principles, and Control","first-page":"301","article-title":"Glycoconjugate vaccine","volume":"2014","author":"Ravenscroft","year":"2015"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0425","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.gt.3301328","article-title":"Clinical retroviral vector production: step filtration using clinically approved filters improves titers","volume":"7","author":"Reeves","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0430","unstructured":"Richter, S., Topell, S. 2013. Process for the preparative purification of virus-like particles (vlps). European Patent EP1893751 B1."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0435","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jbiotec.2006.12.023","article-title":"The use of chitosan as a flocculant in mammalian cell culture dramatically improves clarification throughput without adversely impacting monoclonal antibody recovery","volume":"128","author":"Riske","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0440","first-page":"s21","article-title":"Meningitis vaccine manufacturing: fermentation harvest procedures affect purification","volume":"24","author":"Robinson","year":"2011","journal-title":"Biopharm Intl."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0445","series-title":"Industrial Scale Suspension Culture of Living Cells","first-page":"348","article-title":"Industrial large scale of suspension culture of insect cells","author":"Rold\u00e3o","year":"2014"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0450","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/bp070414x","article-title":"Advances in primary recovery: centrifugation and membrane technology","volume":"24","author":"Roush","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0455","series-title":"Process Scale Bioseparations for the Biopharmaceutical Industry","first-page":"1","article-title":"Harvest of a therapeutic protein product from high cell density fermentation broths: principles and case study","author":"Russell","year":"2007"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0460","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0166-0934(94)90005-1","article-title":"A single method for obtaining highly viable virus from culture supernatant","volume":"46","author":"Saha","year":"1994","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0465","series-title":"AIChE Annual Meeting, November 8\u201313, Salt Lake City, UT, USA","article-title":"Purification and recovery of infectious virus particles using osmolyte flocculation","author":"Saksule","year":"2015"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0470","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/bit.24848","article-title":"Clarification of recombinant proteins from high cell density mammalian cell culture systems using new improved depth filters","volume":"110","author":"Singh","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0475","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1389-1723(02)80126-8","article-title":"Tangential flow filtration technology applicable to large scale recovery of diphtheria toxin","volume":"94","author":"Sundaran","year":"2002","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0480","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10295-008-0428-4","article-title":"Purification of capsular polysaccharide produced by Haemophilus influenzae type b through a simple, efficient and suitable method for scale-up","volume":"35","author":"Takagi","year":"2008","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0485","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/bit.24798","article-title":"Scale-down of the inactivated polio vaccine production process","volume":"110","author":"Thomassen","year":"2013","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083374","article-title":"Next generation inactivated polio vaccine manufacturing to support post-polio-eradication biosafety goals","volume":"8","author":"Thomassen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0495","unstructured":"Thompson, M., Wee, J., Nagpal, A., 2012. Methods for purification of viruses. European patent application EP2334328 A4."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0500","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.seppur.2014.12.002","article-title":"Complete clarification solution for processing high density cell culture harvests","volume":"141","author":"Tomic","year":"2015","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0505","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biologicals.2007.02.002","article-title":"Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor","volume":"35","author":"Toriniwa","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0510","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/btpr.2061","article-title":"Mechanistic evaluation of virus clearance by depth filtration","volume":"31","author":"Venkiteshwaran","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0515","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.biotechadv.2011.07.004","article-title":"Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances","volume":"29","author":"Vicente","year":"2011","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0520","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J. Invertebr. Pathol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0525","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/elsc.201300093","article-title":"Fully aseptic single-use cross flow filtration system for clarification and concentration of cytomegalovirus-like particles","volume":"14","author":"Vicente","year":"2014","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0535","series-title":"Insect Cell Cultures: Fundamental and Applied Aspects","author":"Vlak","year":"1996"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0540","series-title":"The Development of Live, Attenuated Rotavirus Vaccines: A Manufacturer's Resource Guide","first-page":"2006","author":"Wainwright","year":"2006"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0545","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-200060020-00002","article-title":"Viral vectors for gene transfer","volume":"60","author":"Walther","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0550","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/bit.20816","article-title":"Comparison of different options for harvest of a therapeutic protein product from high cell density yeast fermentation broth","volume":"94","author":"Wang","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0555","unstructured":"Weggeman, M., Joannes, E., Corven, J.V., 2006. Virus purification methods. United States patent application US20070207461 A1."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0560","first-page":"88","article-title":"Requirements for diptheria, tenatus, pertussis and combined vaccines. Requirements for biological substances Nos. 8 and 10. WHO Tech","volume":"800","author":"WHO","year":"1990","journal-title":"Rep. Ser."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0565","author":"WHO"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0570","first-page":"273","article-title":"Recommendations to assure the quality, safety and efficacy of tetanus vaccines (adsorbed)","volume":"980","author":"WHO","year":"2014","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0575","unstructured":"Williams, G.V., Hughes, K., 2004. Improvements in virus production. Worldwide patent application WO 2004113518 A1."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0580","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1586\/erv.11.111","article-title":"Downstream processing of cell culture-derived virus particles","volume":"10","author":"Wolf","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0585","first-page":"209","article-title":"The susceptibility of the chorio-allantoic membrane of chick embryos to infection with the fowl-pox virus","volume":"7","author":"Woodruff","year":"1931","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0590","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4161\/hv.20042","article-title":"Hepatitis E vaccine development: a 14year odyssey","volume":"8","author":"Wu","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0595","first-page":"1537","article-title":"Production and purification of plasmid DNA vaccines: is there scope for further innovation? Expert Rev","volume":"13","author":"Xenopoulos","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0600","article-title":"Production and Purification of Hepatitis C Virus-like Particles [Webinar]","author":"Xenopoulos","year":"2015"},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4142\/jvs.2004.5.2.125","article-title":"Biophysical characterization of Japanese encephalitis virus (KV1899) isolated from pigs in Korea","volume":"5","author":"Yang","year":"2004","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0610","first-page":"62","article-title":"The clarification of bioreactor cell cultures for ciopharmaceuticals","volume":"27","author":"Yavorsky","year":"2003","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0615","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1021\/bp050274w","article-title":"Exploitation of the adsorptive properties of depth filters for host cell protein removal during monoclonal antibody purification","volume":"22","author":"Yigzaw","year":"2006","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0620","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4161\/hv.7.2.14121","article-title":"Immunogenicity of a scalable inactivated rotavirus vaccine in mice","volume":"2","author":"Zhang","year":"2011","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.biotechadv.2015.11.005_bb0625","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1016\/j.vaccine.2014.05.064","article-title":"Robust manufacturing and comprehensive characterization of recombinant hepatitis E virus-like particles in Hecolin\u00ae","volume":"32","author":"Zhang","year":"2014","journal-title":"Vaccine"}],"container-title":["Biotechnology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975015300550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0734975015300550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T02:02:13Z","timestamp":1653703333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0734975015300550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0734975015300550"],"URL":"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.11.005","relation":{},"ISSN":["0734-9750"],"issn-type":[{"value":"0734-9750","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clarification of vaccines: An overview of filter based technology trends and best practices","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biotechadv.2015.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}